Publications and communications of Morgan VANDERMEULEN

Navez, M.* , Pinto Coelho, T., El Karouni Walid, ERPICUM, P., Vandermeulen, M., Lagny, M.-G., CHERAMY-BIEN, J.-P., Malisoux, C., GUARIN, C., Thierry, G., Delanaye, P., Cavalier, E., Gilbo, N., Jouret, F.* , & Detry, O.*. (15 March 2024). Development of a model of simultaneous normothermic perfusion of kidney grafts in the pig [Paper presentation]. Congrès Société Belge de Transplantation, Bruxelles, Belgium.
* These authors have contributed equally to this work.

Cirillo, A., Vandermeulen, M., ERPICUM, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (09 March 2024). Untargeted NMR-based metabolomics analysis of kidney allograft perfusates identifies a signature of delayed graft function. Metabolomics, 20 (2), 39. doi:10.1007/s11306-024-02106-1

Vandermeulen, M. (2023). Mesenchymal Stromal Cells in Liver Transplantation, Translational Investigations from a phase I-II Clinical Trial to a Rodent Model of Acute Graft Rejection [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/308176

Cirillo, A., Vandermeulen, M., Erpicum, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (18 June 2023). Untargeted 1H NMR-based analysis of kidney allograft perfusates identifies a metabolomics signature of delayed graft function [Poster presentation]. Metabolomics Society, Niagara Falls, Canada.

LAMBRECHT, C., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., AMICONE, C., Warling, O., Lamproye, A., Delwaide, J., MEURISSE, N., Honoré, P., Hustinx, R., Lovinfosse, P., & Detry, O. (March 2023). 18FDG PET scanner as a selection criterion in liver transplantation for hepatocarcinoma. Acta Gastro-Enterologica Belgica, 86 (1), 17.

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.

AMICONE, C., Ledoux, D., MEURISSE, N., Honoré, P., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., Warling, O., Lamproye, A., KABA, A., JORIS, J., Delwaide, J., & Detry, O. (August 2022). Impact of donor age over 70 years in donation after circulatory death liver transplantation: a 15 years of experience. Transplantation, 106 (8S), 73 (LB-O-15.

AMICONE, C., Ledoux, D., MEURISSE, N., Honoré, P., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., Warling, O., Lamproye, A., KABA, A., Joris, J., Delwaide, J., & Detry, O. (05 May 2022). IMPACT OF DONOR AGE OVER 70 YEARS IN DONATION AFTER CIRCULATORY DEATH LIVER TRANSPLANTATION : A 15 YEARS OF EXPERIENCE [Paper presentation]. Belgian Surgical Week 2022, Ostende, Belgium.

VANDERMEULEN, M., Verscheure, D., & Genser, L. (February 2022). Aorto-duodenal fistula secondary to aortic graft replacement. Acta Chirurgica Belgica, 122 (1), 74-75. doi:10.1080/00015458.2021.2021719

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., JOURET, F., & DETRY, O. (2022). Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats. Frontiers in Immunology, 13, 877953. doi:10.3389/fimmu.2022.877953

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323

VANDERMEULEN, M., LIM, C., GOUMARD, C., & SCATTON, O. (October 2021). Standardized Technique of Selective Left Liver Vascular Exclusion During Laparoscopic Liver Resection for Benign and Malignant Tumors. Journal of Gastrointestinal Surgery, 25 (10), 2720-2725. doi:10.1007/s11605-021-05059-1

Malisoux, C., KOCH, J.-N., MEURISSE, N., Lagny, M., VANDERMEULEN, M., HONORE, P., JOURET, F., DELANAYE, P., & DETRY, O. (August 2021). Perioperative risk factors of acute kidney injury post liver transplantation: a monocentric retrospective cohort study of 260 patients. Transplant International, 34 (S1 POS315), 312.

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., Drion, P., JOURET, F., & DETRY, O. (August 2021). Mesenchymal stromal cells combined with everolimus promote Treg expansion but do not synergize in a rat liver transplant rejection model. Transplant International, 34 (S1 OP519), 101.

VANDERMEULEN, M., Mohamed Wais, M., DELBOUILLE, M.-H., MAGGIPINTO, G., BEGUIN, Y., & DETRY, O. (August 2021). Long term follow-up of liver transplant recipients after allogeneic mesenchymal stromal cell infusion. Transplant International, 34 (S1 OP282), 45.

VANDERMEULEN, M., MOISE, M., MEURISSE, N., Honoré, P., Meurisse, M., Meunier, P., & Detry, O. (June 2020). Image in transplantation surgery: median arcuate ligament in liver transplantation. Acta Chirurgica Belgica, 120, 217-219. doi:10.1080/00015458.2019.1689649

VANDERMEULEN, M., ERPICUM, P., WEEKERS, L., BRIQUET, A., LECHANTEUR, C., Detry, O., Beguin, Y., & Jouret, F. (May 2020). Mesenchymal Stromal Cells in Solid Organ Transplantation. Transplantation, 104 (5), 923-936. doi:10.1097/TP.0000000000003077

Vandermeulen, M., ERPICUM, P., POMA, L., Detry, O., & JOURET, F. (11 March 2020). Impact of mesenchymal stromal cells and/or everolimus on T-reg lymphocyte expansion in rats [Paper presentation]. Annual Meeting, Antwerp, Belgium.

Schielke, A. A., Paolucci, M., MEURISSE, N., Vandermeulen, M., LAMPROYE, A., DELWAIDE, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (October 2019). A SINGLE CENTER EXPERIENCE WITH 157 CONTROLED DCD-LIVER TRANSPLANTATIONS. Transplant International, 32 (S2), 029 p165.

Schielke, A. A., Paolucci, M., MEURISSE, N., VANDERMEULEN, M., LAMPROYE, A., Delwaide, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (16 May 2019). Single center experience in 157 controlled DCD-liver tranplantation [Paper presentation]. 25th Annual International Congress, Toronto, Canada.

Piette, E., VANDERMEULEN, M., MEURISSE, N., Schielke, A. A., MEURIS, C., Honoré, P., & DETRY, O. (2019). Early listeriosis after liver transplantation: report of two cases. Transplant Infectious Disease, 131122. doi:10.1111/tid.13122

Piette, E., VANDERMEULEN, M., MEURISSE, N., Schielke, A. A., MEURIS, C., HONORE, P., & DETRY, O. (14 March 2019). Early listeriosis after liver transplantation: report of 2 cases [Poster presentation]. 26th annual meeting, Anvers, Belgium.

Schielke, A. A., Paolucci, M., MEURISSE, N., VANDERMEULEN, M., LAMPROYE, A., DELWAIDE, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (14 March 2019). A single center experience with 157 controlled DCD liver transplantation [Paper presentation]. 26th annual meeting, Anvers, Belgium.

Schielke, A. A., Paolucci, M., MEURISSE, N., VANDERMEULEN, M., LAMPROYE, A., DELWAIDE, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (29 November 2018). A SINGLE CENTER EXPERIENCE WITH 157 CONTROLED DCD-LIVER TRANSPLANTATIONS [Paper presentation]. 14eme Congrès Francophone de Chirurgie Digestive et Hépato-Bilio-Pancréatique, Marne la Vallée, France.

VANDERMEULEN, M., MEURISSE, N., DAMAS, P., KABA, A., LAMPROYE, A., DELWAIDE, J., JORIS, J., HONORE, P., & DETRY, O. (15 March 2018). Liver transplantation in Jehovah’s Witnesses: a single center-experience [Paper presentation]. Joint NTV-BTS Transplantation congress, Rotterdam, Netherlands.

VANDERMEULEN, M., MEURISSE, N., DAMAS, P., KABA, A., LAMPROYE, A., DELWAIDE, J., JORIS, J., HONORE, P., & DETRY, O. (January 2018). Liver transplantation in Jehovah's witnesses. Acta Gastro-Enterologica Belgica, 81 (1), 30.

MEURISSE, N., Smet, H., LEDOUX, D., VANDERMEULEN, M., GOREUX, J.-P., KABA, A., JORIS, J., HONORE, P., & DETRY, O. (September 2017). Surgical factors and not donor type per se are risk factors for acute kidney injury after liver transplantation. Transplant International, 30 (S2), 106-107 (OS298.

VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12.

VANDERMEULEN, M., & DETRY, O. (07 December 2015). Laparoscopic management of a traumatic lumbar hernia: about a case [Paper presentation]. Cases "à la carte", Brussels, Belgium.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., HONORE, P., & BEGUIN, Y. (November 2015). Infusion of third-party mesenchymal stem cells after liver transplantation: a phase-1, open-label, clinical study. Transplant International, 28 (S4), 10/O27.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (April 2015). Infusion of third-party mesenchymal stromal cells after liver transplantation: a phase 1, open-label, clinical study. Journal of Hepatology, 62 (S2), 311 (P0052.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (27 March 2015). Infusion of third-party mesenchymal stromal cells after liver transplantation: a phase 1, open-label, clinical study [Poster presentation]. 22nd Annual Meeting, Brussels, Belgium.

Detry, O., Govaerts, L., De Roover, A., VANDERMEULEN, M., MEURISSE, N., Malenga, BLETARD, N., Mbendi, C., LAMPROYE, A., Honoré, P., MEUNIER, P., Delwaide, J., & Hustinx, R. (14 March 2015). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. World Journal of Gastroenterology, 21 (10), 3049-54. doi:10.3748/wjg.v21.i10.3049

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (March 2015). Infusion of third-party mesenchymal stream cells after liver transplantation: a phase-1, open-label, clinical study. Acta Gastro-Enterologica Belgica, 78 (1), 29.

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.

MEURISSE, N., DETRY, O., Govaerts, L., DE ROOVER, A., VANDERMEULEN, M., Malenga, S., BLETARD, N., Mbendi, C., LAMPROYE, A., HONORE, P., MEUNIER, P., Delwaide, J., & HUSTINX, R. (September 2014). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. Transplant International, 27 (S2), 18 (EP-17.

MEURISSE, N., DETRY, O., GOVAERTS, L., DE ROOVER, A., VANDERMEULEN, M., MALENGA, BLETARD, N., MBENDI, C., LAMPROYE, A., HONORE, P., MEUNIER, P., DELWAIDE, J., & HUSTINX, R. (2014). Prognostic value of 18f-fdg PET - CT in liver transplantation for hepatocarcinoma [Poster presentation]. 8 th ELITA ELTR MEETING, Prague, Czechia.

VANDERMEULEN, M., GREGOIRE, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & DETRY, O. (2014). Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World Journal of Gastroenterology, 20 (44), 16418-32. doi:10.3748/wjg.v20.i44.16418